E-mail
Contact Us
home Drug Peptide Retatrutide

Retatrutide

CAS No.: 2381089-83-2
Retatrutide Chemical Structure

Molecular formula:C221H342N46O68

Molecular weight: 4731.33

Patent period: Compound: 2026 Composition: 2029

Dositive specifications:–

Injection (type II diabetes, OZEMPIC): —

Oral tablets: —

Injection : —

Products are for laboratory research use only. Not for human use. We do not sell to patients.
Biological Activity

Retarutide (LY3437943) is a triple agonist peptide of glucagon receptor (GCGR), glucose-dependent insulin-promoting peptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is a peptide composed of about 40 amino acids and contains double targets in its sequence. Retarutide inhibited human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775nM, respectively. Retarutide can be used for obesity research.

Chemical Properties
ACTIONS
CAS NO. 2381089-83-2
FORMULA C221H342N46O68
M. WT 4731.33
PURITY > 98%
SYNONYMS LY3437943
STORAGE

Online Inquiry
Product Online Inquiry
Other Drug Peptide More+